TAGOMICS IS
DECODING DISEASE BY
Harnessing the power of multiomics to accelerate
disease
understanding
and diagnosis.
OUR TECHNOLOGY
Working to transform disease diagnosis through comprehensive multiomic profiling.
Tagomics' proprietary multiomic platform unlocks disease-associated biomarkers from a range of biological sources including genetic, epigenetic, and fragmentomic features. In combination with our advanced bioinformatic and machine learning approaches our platform provides unique biological insights and offers a step change in genomics-based disease profiling and diagnosis.
BENEFITS
Our technology enables high-throughput and economical multiomic disease profiling.
Low sample input
Automatable
Sample agnostic
Reliable and reproducible
CAREER OPPORTUNITIES
Interested in being
part of our team?
Tagomics is developing cutting-edge epigenomic based technologies for clinical application. If you are looking to advance your career and want to make an impact in a fast-paced, future-focused environment, check out our vacancies.
STAY UP TO DATE
Latest News
Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.
Tagomics partners with Agilent Technologies
Tagomics has developed Interlace™, a seamless solution for multiomic profiling that enables the identification of disease-associated DNA biomarkers from a range of sample types.
Tagomics Seeks Unmethylated Genomic Regions as Part of Data Package for Drug Development
Tagomics, a UK-based startup, has recently emerged from stealth with a new way to look at methylation, or lack thereof, in the human genome.
Contact Us.
For more information, please feel free to get in touch by completing the enquiry form. We aim to respond to all enquiries within 24 hours.
TAGOMICS IS DECODING DISEASE BY
Harnessing the power of
multiomics to accelerate
disease understanding
and diagnosis.
OUR TECHNOLOGY
Working to transform disease diagnosis through comprehensive multiomic profiling.
Tagomics' proprietary multiomic platform unlocks disease-associated biomarkers from a range of biological sources including genetic, epigenetic, and fragmentomic features. In combination with our advanced bioinformatic and machine learning approaches our platform provides unique biological insights and offers a step change in genomics-based disease profiling and diagnosis.
BENEFITS
Our technology enables high-throughput and economical multiomic disease profiling.
Low sample input
Automatable
Sample agnostic
Reliable and reproducible
CAREER OPPORTUNITIES
Interested in being
part of our team?
Tagomics is developing cutting-edge epigenomic based technologies for clinical application. If you are looking to advance your career and want to make an impact in a fast-paced, future-focused environment, check out our vacancies.
STAY UP TO DATE
Latest News
Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.
Tagomics partners with Agilent Technologies
Tagomics has developed Interlace™, a seamless solution for multiomic profiling that enables the identification of disease-associated DNA biomarkers from a range of sample types.
Tagomics Seeks Unmethylated Genomic Regions as Part of Data Package for Drug Development
Tagomics, a UK-based startup, has recently emerged from stealth with a new way to look at methylation, or lack thereof, in the human genome.
